Opendata, web and dolomites

NEUROON-MED SIGNED

NEUROON-MED – the future of at-home diagnosis of sleep disorders

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NEUROON-MED project word cloud

Explore the words cloud of the NEUROON-MED project. It provides you a very rough idea of what is the project "NEUROON-MED" about.

cagr    more    oximetry    calculated    polysomnography    moderate    inteliclinic    risk    home    diagnosis    mask    algorithms    markets    85    suffer       screening    effectiveness    clinical    pulse       standard    combined    accounts    life    medical    2019    solutions    med    perfectly    worldwide    smei    variants    additionally    never    economic    15    competitors    remote    neuroon    advantage    intelligence    data    span    excellence    stopping    expectancy    sa    device    sensors    customers    registration    artificial    diagnostic    diagnosing    specialists    eeg    world    lower    limited    gold    harvard    eye    shorter    apnea    rate    disorders    90    sleep    treatment    crashes    monitors    2018    billion    vehicle    movements    market    stages    million    commercialisation    fast    aligned    motor    inexpensive    psg    technological    brainwaves    diagnosed    epidemic    solution    medicine    people    sevenfold    eog    distinguishing    severe    price    115    school    massive   

Project "NEUROON-MED" data sheet

The following table provides information about the project.

Coordinator
INTELICLINIC SP. Z.O.O. 

Organization address
address: KIJOWSKA 3
city: WARSZAWA
postcode: 03-738
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Project website https://neuroonopen.com/
 Total cost 2˙321˙250 €
 EC max contribution 1˙624˙875 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2017
 Duration (year-month-day) from 2017-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INTELICLINIC SP. Z.O.O. PL (WARSZAWA) coordinator 1˙624˙875.00

Map

 Project objective

More than 100 million people suffer from sleep apnea (SA) worldwide according to the WHO data. People with SA have a life expectancy 20 years shorter than the average life span. Additionally, they have a three- to sevenfold increased risk of motor vehicle crashes. The economic impact of sleep disorders is massive, specialists from the Harvard School of medicine calculated that costs of SA only in the US accounts for $115 billion every year. The main problem the world is facing with stopping the SA epidemic is not a treatment but diagnosis. It is estimated that 85% of people who suffer from SA have never been diagnosed. The reason for the low screening rate of SA is a limited access to polysomnography (PSG) – the gold standard for testing sleep disorders. At Inteliclinic, we have developed the NeuroOn-MED mask which is addressing the customers need for effective and inexpensive solution for home diagnosis of SA. Our advantage over competitors is built upon the technological excellence of NeuroOn-MED, which analyses the brainwaves and eye movements in the same way as PSG does. The sensors of NeuroOn-MED (EEG, EOG, pulse oximetry, and others) combined with artificial intelligence algorithms for sleep data analysis provide 90% of PSG effectiveness, allowing for distinguishing between sleep stages and various variants of SA. Comparing with the currently offered home sleep monitors which are capable only of diagnosing moderate and severe SA cases. Moreover, the price of our device will be lower than currently offered solutions. NeuroOn-MED is perfectly aligned with new trends in remote diagnosis of sleep disorders. The market of SA diagnostic devices is expected to reach a value of $7.3 billion in 2018, with a CAGR of 15.0%. The proposed SMEI-funded project will be focused on clinical studies of the NeuroOn-MED, which will lead to registration as a medical device and fast commercialisation on European and US markets in 2019-20.

 Deliverables

List of deliverables.
NeuroOn-MED product specification Documents, reports 2020-01-31 16:50:17

Take a look to the deliverables list in detail:  detailed list of NEUROON-MED deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NEUROON-MED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NEUROON-MED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

Meshporto_smeIns1_2 (2018)

PsstMenu allows customers to place orders directly from home or restaurant tables using only a smartphone.

Read More  

oWBI (2018)

Osmotic Wearable Bolus Injector (oWBI) for viscous drug delivery

Read More